Form 8-K - Current report:
SEC Accession No. 0001558370-25-003807
Filing Date
2025-03-27
Accepted
2025-03-27 16:02:11
Documents
16
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20250327x8k.htm   iXBRL 8-K 30574
2 EX-99.1 ganx-20250327xex99d1.htm EX-99.1 160768
3 GRAPHIC ganx-20250327xex99d1001.jpg GRAPHIC 5710
  Complete submission text file 0001558370-25-003807.txt   342948

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20250327.xsd EX-101.SCH 4031
5 EX-101.DEF ganx-20250327_def.xml EX-101.DEF 2826
6 EX-101.LAB ganx-20250327_lab.xml EX-101.LAB 17907
7 EX-101.PRE ganx-20250327_pre.xml EX-101.PRE 10618
18 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20250327x8k_htm.xml XML 5028
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 25779205
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)